法国孕产妇静脉血栓栓塞死亡全国分析
基于法国孕产妇死亡保密调查系统,回顾性分析2007至2018年因静脉血栓栓塞(VTE)死亡的孕产妇。12年间99例VTE相关死亡,孕产妇死亡率稳定在约1.0/10万活产。46.2%的VTE相关死亡被认为可预防,多数死亡者存在累积的中危因素及产科并发症相关获得性因素。
要点
- 近半数VTE相关孕产妇死亡被认为可预防。
- 多数死亡者仅有中危因素,且常为多重中危因素叠加。
- 产后VTE死亡者中37.2%有产后出血或子痫前期等产科并发症相关获得性因素。
核心结论
- 近半数VTE相关孕产妇死亡被认为可预防,且该比例随时间无显著变化。
- 死亡者中累积性中危VTE因素及产科并发症相关获得性因素的发生率较高。
- 需在妊娠过程中反复评估VTE风险的动态变化以改善医疗质量。
研究设计与样本
- 基于法国全国孕产妇死亡保密调查系统ENCMM的回顾性描述性研究。
- 纳入2007至2018年法国所有因VTE事件导致的孕产妇死亡病例。
- 按VTE发生时间分为产前组与产后组,分析80例有完整保密调查数据的死亡病例。
主要发现
- 12年间99例VTE相关孕产妇死亡,对应孕产妇死亡率稳定在约1.0/10万活产。
- 80例纳入分析者中,产前VTE 37例(46.2%),产后VTE 43例(53.8%)。
- 产前组67.6%(25/37)存在危险因素,产后组93.0%(40/43)存在危险因素。
- 62.5%的死亡者仅有中危因素,其中66.7%存在两个或以上中危因素叠加。
- 产后VTE死亡者中37.2%(16/43)存在产后出血或子痫前期等产科并发症相关获得性因素。
关键数值与推荐
- 产前VTE死亡者中危险因素检出率为67.6%(25/37)。
- 产后VTE死亡者中危险因素检出率为93.0%(40/43)。
- 产后VTE死亡者中37.2%(16/43)有产科并发症相关获得性因素。
- 30/80(37.5%)的死亡者按国家指南有血栓预防指征,其中产前2例(5.4%),产后28例(65.1%)。
- 有血栓预防指征的30例中,13例(43.3%)未接受血栓预防,8例(26.7%)剂量或疗程不当。
临床怎么用
- 应在妊娠全程反复评估VTE风险,重视累积性中危因素的动态变化。
- 对产后出血或子痫前期等产科并发症患者需警惕获得性VTE风险。
- 对有血栓预防指征者应确保正确实施,避免漏用及剂量或疗程不当。
局限性
- 该研究未对VTE相关孕产妇死亡的可预防性判断随时间的变化趋势作统计学检验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the clinical profile, management, and potential preventability of maternal deaths from venous thromboembolism (VTE) based on data from the French maternal mortality surveillance system. METHODS: We conducted a retrospective descriptive study of all maternal deaths that resulted from a VTE event in France from 2007 to 2018. Deaths were identified through the nationwide permanent enhanced maternal mortality surveillance system-ENCMM (Enquête Nationale Confidentielle sur les Morts Maternelles [French National Confidential Enquiry into Maternal Deaths]). Women were considered for two groups based on the time of VTE onset, antepartum or postpartum. Maternal characteristics, clinical features, and preventability factors were described for these two groups. RESULTS: During the 12-year study period, 99 women died from VTE, and the corresponding maternal mortality ratio remained stable, at around 1.0 per 100,000 live births. Analyses were conducted on 80 maternal deaths that resulted from antepartum (n=37, 46.2%) and postpartum (n=43, 53.8%) VTE with available data from confidential inquiry. Risk factors were found in 67.6% (25/37) of antepartum cases and 93.0% (40/43) of postpartum cases. Most women (62.5%) only had moderate risk factors, most often multiple (two or more, 66.7%). Among women who died from postpartum VTE, 37.2% (16/43) had acquired risk factors resulting from obstetric conditions (postpartum hemorrhage or preeclampsia). Overall, 46.2% of VTE-related maternal deaths were considered preventable and this proportion did not significantly change over time. According to national guidelines, thromboprophylaxis was indicated in 30 of 80 (37.5%) women who died from antepartum and postpartum VTE (two in the antepartum period, 5.4%; 28 in the postpartum period, 65.1%). Of these women, 13 (43.3%) did not receive thromboprophylaxis and eight (26.7%) received an inappropriate dose or duration of thromboprophylaxis. CONCLUSION: Nearly half of VTE-related maternal deaths were preventable. Women who died had a high prevalence of cumulative moderate VTE risk factors as well as acquired factors related to obstetric complications. This underlines the importance of repeated assessment along pregnancy to integrate the evolutionary nature of VTE risk in the obstetric population and improve the quality of care.
引用
- Rigouzzo, Rossignol, Jonard, et al. Nationwide Analysis of Maternal Mortality Due to Venous Thromboembolism. Obstet Gynecol. 2026. PMID: 41818752. doi:10.1097/AOG.0000000000006233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。